DON'T WAIT, VACCINATE YOUR CHILDREN!
The prevalence of oral HPV infection was higher among men than women in the United States, with approximately 11 million men and 3.2 million women affected nationwide, according to recent data published in Annals of Internal Medicine.
Researchers sought to determine the population-based prevalence and risk factors of oral HPV infection, and to characterize the concordance of oral and genital HPV infection among men and women in the United States. They evaluated oral rinse, penile swab and vaginal swab specimens from adults aged 18 to 69 years enrolled in the National Health and Nutrition Examination Survey from 2011 to 2014.
The prevalence of high-risk HPV infection was 12.7% (95% CI, 7-18.4) among men and 3.6% (95% CI, 1.4-5.9) among women with same-sex partners, and was 22.2% (95% CI, 9.6-34.8) among men with two or more same-sex oral sex partners. Oral HPV prevalence among men with concurrent genital HPV infection was four times greater than among those without it.
Further research is necessary to determine the best prevention strategies to target oral HPV infection and associated types of oral cancer. Future study should also specifically work to identify the effectiveness of vaccination in older people, an area that remains unclear.
NO BRASIL, A VACINAÇÃO ESTÁ DISPONÍVEL PARA MENINAS DE 9 A 14 ANOS DE IDADE E
MENINOS DE 12 A 13 ANOS DE IDADE =
1 DOSE + 1 REFORÇO DECORRIDOS 6 MESES DA PRIMEIRA DOSE.
FONTES:
Ministério da Saúde do Brasil.
Nenhum comentário:
Postar um comentário